Suzanne Blaug
Director/Board Member at FIBROGEN, INC.
Net worth: 50 067 $ as of 2024-03-30
Profile
Suzanne Blaug is an Independent Director at FibroGen, Inc. She previously worked as Managing Director at Johnson & Johnson, SVP-Global Marketing & Commercial Development at Amgen, Inc., Head at Janssen Alzheimer Immunotherapy, Principal at EMEA Capital LLP, and Vice President-Europe Strategic Marketing at Janssen Global Services LLC.
Blaug holds an undergraduate degree from The University of North Carolina at Chapel Hill and an MBA from Kellogg School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
FIBROGEN, INC.
0.02% | 2024-03-30 | 21,305 ( 0.02% ) | 50 067 $ | 2024-03-30 |
Suzanne Blaug active positions
| Companies | Position | Start |
|---|---|---|
| FIBROGEN, INC. | Director/Board Member | 2019-06-04 |
Former positions of Suzanne Blaug
| Companies | Position | End |
|---|---|---|
| AMGEN INC. | Sales & Marketing | 2018-07-31 |
| Janssen Alzheimer Immunotherapy | Corporate Officer/Principal | 2012-02-29 |
Janssen Global Services LLC
 Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Corporate Officer/Principal | 2009-09-30 |
EMEA Capital LLP
 EMEA Capital LLP Investment ManagersFinance EMEA Capital LLP is a privately-held investment management firm which was founded by Osman Semerci in 2008. Headquartered in London, the firm provides asset management services to individual and institutional clients. | Corporate Officer/Principal | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Training of Suzanne Blaug
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| FIBROGEN, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| Janssen Alzheimer Immunotherapy | |
EMEA Capital LLP
EMEA Capital LLP Investment ManagersFinance EMEA Capital LLP is a privately-held investment management firm which was founded by Osman Semerci in 2008. Headquartered in London, the firm provides asset management services to individual and institutional clients. | Finance |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Health Technology |
- Stock Market
- Insiders
- Suzanne Blaug